Home > Share Market > Stocks > Bliss GVS Pharma LTD > Financial Statements > BLISSGVS Key Financial Ratios

Bliss gvs pharma Financial Statements

BLISSGVS Ratio Analysis

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar Mar-2022 Mar-2021 Mar-2020 Mar-2018
Growth matrix (%)        
Revenue growth 29.50 (16) (15) 2.03
Op profit growth 11 (13) (37) (2.80)
EBIT growth 20.90 (26) (27) 3.69
Net profit growth (78) (30) 65.50 (28)
Profitability ratios (%)        
OPM 15.80 18.50 17.90 24.20
EBIT margin 17.70 19 21.40 24.80
Net profit margin 2.01 11.90 14.10 7.22
RoCE 13.70 11.90 18.90 27.70
RoNW 0.46 2.22 3.82 2.87
RoA 0.39 1.86 3.12 2.01
Per share ratios ()        
EPS 2.23 7.17 9.23 8.60
Dividend per share 0.50 0.50 0.50 1
Cash EPS (0.20) 4.97 8.21 3.63
Book value per share 79 78.40 71.30 52
Valuation ratios        
P/E 34.50 13.80 10.90 22.70
P/CEPS (348) 19.90 12.30 53.90
P/B 0.97 1.26 1.41 3.76
EV/EBIDTA 4.87 7.85 6.63 9.14
Payout (%)        
Dividend payout -- -- -- 17.50
Tax payout (24) (29) (24) (32)
Liquidity ratios        
Debtor days 209 320 224 124
Inventory days 54.40 55.60 36 24.30
Creditor days (57) (68) (49) (59)
Leverage ratios        
Interest coverage (28) (20) (27) (8.90)
Net debt / equity (0.10) -- 0.03 0.05
Net debt / op. profit (0.60) (0.20) 0.19 0.15
Cost breakup ()        
Material costs (52) (57) (64) (48)
Employee costs (10) (12) (7.80) (8.50)
Other costs (22) (13) (11) (19)

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

Open Demat Account
  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity